Loading...
8 Generic Drugs Reports
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Sanofi, Pfizer, Teva Pharmaceutical Industries, Abbott Laboratories, Sun Pharmaceuticals Industries
Study Period: 2019 - 2030
Country Covered: Sweden
Major Players: Amgen, Pfizer, Orifarm Group, Merck, Novartis
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Akorn, Cipla, Novartis, Teva Pharmaceutical Industries, Apotex
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Eli Lilly and Company, Lupin, Viatris Inc.(Mylan Pharmaceuticals Inc.), Teva Pharmaceutical Industries, Zydus Lifesciences
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Fresenius, Novartis, Pfizer, Teva Pharmaceutical Industries, Hikma Pharmaceuticals
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Novartis, Astellas Pharma, Aurinia Pharmaceuticals Inc., Novaliq, Otsuka Pharmaceuticals
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Asia Pacific, Middle East and Africa, South America
Major Players: Pfizer, Novartis, Biogen, Zydus Group (Cadila Healthcare Limited), H. Lundbeck
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Pfizer, Teva Pharmaceutical Industries, Sun Pharmaceuticals Industries, Cipla, Novartis
Filter Reports
By Region
By Countries
